Arecco, Luca
Lambertini, Matteo
Article History
First Online: 6 July 2023
Competing interests
: M.L. has acted as an advisor of Astrazeneca, Exact Sciences, Gilead, Lilly, MSD, Novartis, Pfizer, Roche and Seagen, has received honoraria as a speaker from Daiichi Sankyo, Libbs, Lilly, Novartis, Pfizer, Roche, Sandoz and Takeda, has received travel grants and institutional research funding from Gilead. L.A. declares no competing interests.